Just "Selling" is costly. Selling, Admin, etc costs still dominate.
UBI still slowly burns its cash.
It would have to double its sales to approach break-even. We hope that will happen. I am not counting newer items because that's "just a hope".
Getting into the medical world is very very difficult/costly/slow. Today's FT looks at "blood tests for cancer" - if UBI can do it, can others be far behind?
Ann: Q1 2023 Results, page-4
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $38.74M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.5¢ | $38.71K | 297.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 44000 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 9900 | 2 |
View Market Depth
| Last trade - 15.24pm 04/11/2024 (20 minute delay) ? |
| UBI (ASX) Chart |